Arcutis Biotherapeutics, Inc. Common Stock
$21.1
USD
Last updated on --.
24h volume2.61M
24h highest21.3400 USD
24h lowest20.7250 USD
24h Price movement+1.15%
ARQT recent prices
24 Hours
+1.15%+$0.24
30 days
-10.80%-$2.530
60 days
-1.56%-$0.33
90 days
-22.66%-$6.120
Key data
Previous close20.8600 USD
Market cap2.56B USD
Volume2.61M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.02000 USD
Net income (FY)-2.38M USD
Revenue (FY)415.62M USD
Last report date6 May 2026
About Arcutis Biotherapeutics, Inc. Common Stock
HeadquartersWESTLAKE VILLAGE
Employees (FY)354.00
Revenue per employee (FY)1.17M USD
Net income per employee (FY)-6.71K USD
Listed onNasdaq
ARQT conversion tables
 |  |
|---|---|
| 0.5 ARQT | 10.55 USD |
| 1 ARQT | 21.1 USD |
| 5 ARQT | 105.5 USD |
| 10 ARQT | 211 USD |
| |
|---|---|
| 0.5 USD | 0.023697 ARQT |
| 1 USD | 0.047393 ARQT |
| 5 USD | 0.23697 ARQT |
| 10 USD | 0.47393 ARQT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ARQT is trading at $21.10, +1.15% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ARQT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ARQT is currently trading at $21.10, +1.15% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ARQT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ARQT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ARQT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ARQT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Arcutis Biotherapeutics, Inc. Common Stock's market cap is currently 2.56B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.61M
24h highest21.3400 USD
24h lowest20.7250 USD
24h Price movement+1.15%
Start trade with ARQT Perpetual
Sign up to trade